Enterprise Startups Worldwide, an Australian startup working below the title Updoc, has raised its first exterior capital. It acquired $20 million in funding from ASX-listed capital investor Bailador.
WHAT IT DOES
Established in 2021, Updoc provides a variety of telehealth providers, together with digital consultations, on-line prescriptions, specialist referrals, pathology referrals, and medical letters. It provides these providers both as a one-off transaction or a month-to-month subscription.
So far, Updoc has served round 200,000 sufferers.
WHAT IT’S FOR
With out freely giving many particulars, Bailador shared that Updoc plans to make use of its contemporary funds to pursue worldwide enlargement. It’ll even be invested in expertise improvement.
“This funding from Bailador will allow us to maneuver extra quickly in direction of serving to tens of millions of individuals with healthcare entry by accelerating product improvement and worldwide enlargement,” Updoc co-founders and co-CEOs Dylan Coyne and Clifton Hodgkinson had been quoted as saying.
MARKET SNAPSHOT
Capital funding in telehealth firms has slowed down lately following the tip of the worldwide COVID-19 pandemic. In Australia, Sydney-based Eucalyptus final made a big elevate, price $42 million, which went to its enlargement in the UK.
Different investments in Australian telehealth got here within the type of mergers and acquisitions. In 2022, Visionflex merged with ASX-listed 1st Group. Final yr, conglomerate Wesfarmers purchased telehealth enterprise InstantScripts for $91 million. Physician Care Wherever, which is now specializing in its core UK market, offered its Australian enterprise GP2U Telehealth to My Emergency Physician for $2 million.